Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-21

Clinical Trial Update: Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis

View source ↗

Summary

This clinical trial evaluating how medications are removed during plasmapheresis in kidney transplant patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Kidney Transplantation, Plasmapheresis | Status: WITHDRAWN